Medy-Tox Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 12, 2022 at 06:14 am
Share
Medy-Tox Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported negative sales was KRW 0.00017 million compared to KRW 0.00018 million a year ago. Net income was KRW 19,234.34 million compared to KRW 31,654.21 million a year ago. Basic earnings per share from continuing operations was KRW 3,044.7619 compared to KRW 4,950.5668 a year ago. Diluted earnings per share from continuing operations was KRW 3,020 compared to KRW 4,848.0726 a year ago. Basic earnings per share was KRW 3,044.7619 compared to KRW 5,198.0952 a year ago. Diluted earnings per share was KRW 3,020 compared to KRW 5,090.4762 a year ago.
For the six months, negative sales was KRW 0.00004 million compared to sales of KRW 0.00017 million a year ago. Net income was KRW 24,283.7 million compared to KRW 86,830.52 million a year ago. Basic earnings per share from continuing operations was KRW 3,687.619 compared to KRW 13,580.0453 a year ago. Diluted earnings per share from continuing operations was KRW 3,659.0476 compared to KRW 13,477.551 a year ago. Basic earnings per share was KRW 3,687.619 compared to KRW 14,259.0476 a year ago. Diluted earnings per share was KRW 3,659.0476 compared to KRW 14,151.4286 a year ago.
Medy Tox Inc is a Korea-based company engaged in the development, manufacture and marketing of biopharmaceuticals. The Companyâs main product is type A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. Its products are also used in chin plastic surgeries. The Company provides its products under the brand names of Medytoxin, Neurox, Siax, and Neuramis. In addition, the Company develops and sells medical devices such as injectors under the brand names of Neurajet, Neurafen and others. The Company also engages in technology transfer. The Company distributes its products in domestic and overseas markets such as Japan, China, Russia and Europe.
MEDY-TOX INC. 
